Mutual of America Capital Management LLC Purchases Shares of 635,531 Stevanato Group S.p.A. (NYSE:STVN)

Mutual of America Capital Management LLC acquired a new position in Stevanato Group S.p.A. (NYSE:STVN - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 635,531 shares of the company's stock, valued at approximately $13,848,000. Mutual of America Capital Management LLC owned about 0.21% of Stevanato Group as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently added to or reduced their stakes in STVN. Van Berkom & Associates Inc. bought a new stake in Stevanato Group during the 4th quarter valued at $39,000. Hardy Reed LLC raised its stake in shares of Stevanato Group by 8.2% during the 3rd quarter. Hardy Reed LLC now owns 11,077 shares of the company's stock valued at $222,000 after purchasing an additional 840 shares during the period. Lindenwold Advisors INC lifted its holdings in Stevanato Group by 13.5% during the 3rd quarter. Lindenwold Advisors INC now owns 11,930 shares of the company's stock worth $239,000 after purchasing an additional 1,415 shares in the last quarter. Raymond James Trust N.A. lifted its holdings in Stevanato Group by 22.6% during the 3rd quarter. Raymond James Trust N.A. now owns 12,556 shares of the company's stock worth $251,000 after purchasing an additional 2,317 shares in the last quarter. Finally, Captrust Financial Advisors boosted its stake in Stevanato Group by 12.7% in the 3rd quarter. Captrust Financial Advisors now owns 13,100 shares of the company's stock worth $262,000 after purchasing an additional 1,480 shares during the period.

Stevanato Group Price Performance

Shares of STVN stock traded up €1.35 ($1.42) during trading on Tuesday, hitting €19.46 ($20.48). The company had a trading volume of 476,141 shares, compared to its average volume of 319,515. The stock's 50-day moving average is €21.48 and its two-hundred day moving average is €20.53. The stock has a market capitalization of $5.89 billion, a price-to-earnings ratio of 41.40, a price-to-earnings-growth ratio of 7.18 and a beta of 0.56. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. Stevanato Group S.p.A. has a 52 week low of €16.56 ($17.43) and a 52 week high of €33.49 ($35.25).

Remove Ads

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on STVN shares. Morgan Stanley reissued an "equal weight" rating and issued a $23.00 price target (down from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. Wolfe Research assumed coverage on shares of Stevanato Group in a report on Friday, December 13th. They set an "outperform" rating and a $28.00 target price on the stock. Finally, Bank of America raised their price target on shares of Stevanato Group from $24.00 to $26.00 and gave the company a "buy" rating in a report on Friday, December 13th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of €28.60 ($30.11).

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.